Executive Oncology Clinical Strategy Leader

GSK plc

Pennsylvania

Hybrid

USD 242,000 - 404,000

Full time

7 days ago
Be an early applicant

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

GSK plc is seeking a Clinical Development Lead (CDL) – Oncology GU to own the clinical strategy and narrative for an asset, influencing governance and investment decisions across the MDT core quad. Hybrid work arrangement with flexible locations in the US, including Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA.

You will lead the evidence base, drive development speed, and mentor senior scientists while collaborating across Medical Affairs, Regulatory, and Commercial for asset

Qualifications

  • MD, PharmD, PhD or equivalent; MD strongly preferred.
  • Minimum 10 years pharmaceutical or relevant scientific, medical, or clinical experience
  • Evidence of strong GU malignancies knowledge, specifically bladder cancer
  • Proven ability to lead cross‑functional teams in a complex matrix environment

Responsibilities

  • Define the asset‑level clinical strategy, scientific narrative and decision framework across the asset lifecycle.
  • Lead governance and investment discussions with senior management and translate evidence into strategic recommendations.
  • Represent Clinical Development in portfolio governance, external engagements and alliance partnerships.
  • Leverage AI‑enabled insights and data platforms to inform asset‑level strategic decisions and speed up development.
  • Develop and mentor clinical development talent within the asset programme.

Skills

Clinical Data Interpretation
Clinical Trial Designs
Clinical Trials Monitoring
Digital Fluency
Drug Development
Drug Regulatory Affairs
Evidence Based Decision Making
Executive Presence
Hematology and Oncology
Learning Agility
Matrix Leadership
Real World Evidence
Scientific Presentations
Strategic Direction

Education

MD/PhD or equivalent

Job description

GSK plc is seeking a Clinical Development Lead (CDL) – Oncology GU to own the clinical strategy and narrative for an asset, influencing governance and investment decisions across the MDT core quad. Hybrid work arrangement with flexible locations in the US, including Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA.

You will lead the evidence base, drive development speed, and mentor senior scientists while collaborating across Medical Affairs, Regulatory, and Commercial for asset

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Chief Oncology Clinical Strategy Lead
Chief Oncology Clinical Strategy Lead

GlaxoSmithKline plc • Upper Providence

Hybrid
USD 242,000 - 404,000
Annual bonus
Health care and insurance benefits
Retirement benefits
+2
Executive Oncology Clinical Development Lead
Executive Oncology Clinical Development Lead

Glaxosmithkline • Waltham (MA)

Hybrid
USD 242,000 - 404,000
Annual bonus
Long-term incentive program
Health care benefits (employee & a
+2
Executive Medical Director, Oncology CD Lead
Executive Medical Director, Oncology CD Lead

Glaxosmithkline • Upper Providence

Hybrid
USD 242,000 - 404,000
Health care benefits
Annual bonus
Long-term incentive program
Executive Oncology ECDL: Early Clinical Development Lead
Executive Oncology ECDL: Early Clinical Development Lead

GlaxoSmithKline plc • Upper Providence

Hybrid
USD 284,000 - 474,000
Annual bonus
Long-term incentive program
Health care
+5
Executive Oncology Medical Director, Early Clinical Development
Executive Oncology Medical Director, Early Clinical Development

Glaxosmithkline • United States

Hybrid
USD 199,000 - 344,000
Health care benefits
Retirement benefits
Paid holidays
+2
Executive Oncology ECDL: Early-Phase Translational Leader
Executive Oncology ECDL: Early-Phase Translational Leader

GSK • Collegeville (PA)

Hybrid
USD 284,000 - 474,000
Executive Oncology Early Clinical Development Leader
Executive Oncology Early Clinical Development Leader

Glaxosmithkline • Waltham (MA)

Hybrid
USD 284,000 - 474,000
Health care
Retirement benefits
Paid holidays
+2
Executive Oncology Early Clinical Development Lead — Hybrid
Executive Oncology Early Clinical Development Lead — Hybrid

GlaxoSmithKline plc • Upper Providence

Hybrid
USD 284,000 - 474,000
Health care
Retirement benefits
Paid holidays
+2
Executive Oncology Early Clinical Development Lead
Executive Oncology Early Clinical Development Lead

Glaxosmithkline • Upper Providence

On-site
USD 241,000 - 321,000
Director, Oncology Clinical Science Leader
Director, Oncology Clinical Science Leader

1925 GlaxoSmithKline LLC • Waltham (MA)

Hybrid
USD 190,000 - 316,000
Health care benefits
Retirement benefits
Paid holidays